New Episode
Short Summary
In this Special Live installment of the Legacies Live series, host Tom Ritchie and StratCann founder David Brown review the major news shaping the cannabis sector. They discuss Quebec’s decision to allow cannabis vape pen sales starting in November under a strict 30% THC cap. David explains how global exports in Australia and Germany act as an economic liferaft for Canadian licensed producers (LPs)—enabling them to clear older inventories, improve domestic wholesale prices, and bypass Canada’s $1-per-gram excise tax. They also analyze the compliance risks for indoor consumption lounges operating under Health Canada’s sensory testing licenses, regional differences in provincial smoking bylaws, and the realities of US rescheduling and descheduling rumors.
Tom Ritchie Says: All right, welcome everyone to Week in Weed live! David, thank you for joining me. You’re dialing in early from British Columbia while I’m here in Ontario with the dogs in studio. There is so much happening in this industry every single week. I always look forward to your StratCann recaps that drop on Saturdays. How are things on the West Coast?
David Brown Says: Good morning, Tom. The weather is lovely today—we had some rain and cool weather that we desperately needed, and now the sunshine is back. Ready to dive into another wild week in cannabis.
Tom Ritchie Says: Where should we kick off? There’s news breaking across provinces and globally. What caught your eye at StratCann this week?
David Brown Says: One of the biggest international stories we’re tracking is the regulatory pushback against medical cannabis access in Australia and New Zealand. The health authorities in both countries are cracking down on prescription outliers and pay-to-play telehealth clinics. It closely mirrors what happened in Canada in the lead-up to legalization when the medical system was the only access channel.
David Brown Says: Australia was the original pressure-release valve for Canadian licensed producers. If their health regulator tightens prescribing guidelines and reins in clinics, that could have significant downstream consequences for Canadian LPs who rely on those export channels.
Tom Ritchie Says: Closer to home, AQIC released their report on Quebec’s cannabis and hemp industries, and there is major movement on vaporizers at the SQDC.
David Brown Says: Exactly. In November, Quebec is finally expected to begin permitting the sale of cannabis vape pens, which have been prohibited in the province since legalization. However, Quebec is strictly enforcing its 30% maximum THC potency cap across all vaporizers. It will be fascinating to see how extractors formulate for that market—we’ll likely see balanced THC/CBD formulations and high-terpene full-spectrum oils rather than high-potency distillates.
Tom Ritchie Says: I watched that SQDC product call closely through Keith Bao and AVEO. Extractors were scrambling to submit compliant formulations under that 30% ceiling. In other provinces, balanced cartridges regularly test at 50% or 60% total cannabinoids, so Quebec is creating a unique product landscape.
David Brown Says: On the corporate front, earnings season arrived with quarterly reports from Cronos, Aurora, Avant Brands, and Canopy Growth. Simultaneously, Ontario law enforcement made headlines: the OPP dismantled an unlicensed dispensary as well as an enormous unlicensed production facility, seizing over 100,000 plants. It’s fascinating seeing the operators and networks tied to these illicit operations.
Tom Ritchie Says: I often flag these stories to mainstream media contacts, but traditional news outlets rarely cover them. The general public simply goes into retail stores to buy their weed without understanding the underground illicit market or regulatory battles happening behind the scenes.
David Brown Says: StratCann has been meticulously documenting and archiving these enforcement actions for years. Mainstream reporting often misses the nuances—who controls these grows, where the capital originates, and how illicit supply leaks into consumer channels. There is an enormous investigative story waiting to be told.
Tom Ritchie Says: Speaking of large-scale operations, Village Farms and Pure Sun Farms have been expanding greenhouse capacity in Delta, BC. You and I both toured that facility recently.
David Brown Says: Pure Sun Farms is one of the few large-scale operators that successfully scaled commercial cultivation while maintaining consistent quality. A critical takeaway from recent earnings reports is that domestic market share is compressing for major LPs, meaning their growth is almost entirely propelled by international medical export.
David Brown Says: Export served as a savior for Canadian producers in two distinct phases. First, it allowed large LPs to flush out aged, subpar vault inventory, which cleared Canadian supply gluts and lifted domestic wholesale pricing. Second, it provided craft and micro-producers a viable route to profitability because international buyers pay $3 to $5 per gram with zero domestic excise tax. But international markets are approaching saturation, so relying entirely on export without maintaining domestic brand presence is high risk.
Tom Ritchie Says: When I toured Pure Sun Farms, they had an entire EU-GMP certified cleanroom packaging finished, labeled retail products ready for direct export. That finished-goods model represents the next level of global trade.
David Brown Says: Australia was Canada’s first major export destination, but that market is plateauing. Germany opened up and absorbed significant Canadian volume, but following their recent elections, political pushback from conservative parties may slow recreational progress. The real opportunity in mature export markets isn’t just shipping raw flower—it’s introducing advanced categories like live rosin, solventless extracts, and vapes.
Tom Ritchie Says: Which international jurisdiction excites you most right now?
David Brown Says: Germany remains the bellwether because its market scale will dictate European Union policy. Conversely, I remain skeptical about rapid federal reform in the United States. Despite rumors about DEA rescheduling or executive descheduling, nothing fundamentally shifts the needle without comprehensive federal legislation from Congress.
David Brown Says: Furthermore, many US Multi-State Operators actively prefer the existing state-by-state status quo because it protects their regional oligopolies. Harmonizing fifty distinct state regulatory frameworks—where Massachusetts enforces strict testing standards while other states operate more loosely—presents an immense logistical nightmare. Banking on an overnight US federal windfall is a dangerous investment thesis.
Tom Ritchie Says: Moving back to Ontario, Club LIT and Joint Craft in Toronto have been pushing the envelope with indoor cannabis consumption spaces. How are they navigating municipal and federal regulations?
David Brown Says: They operate under Health Canada research licenses—specifically organoleptic sensory testing licenses that permit human consumption for evaluation purposes. Club LIT worked closely with Toronto municipal bylaws, installing specialized commercial ventilation and air filtration systems. In Ontario, municipal bylaws can permit indoor research exemptions, whereas British Columbia enforces strict provincial tobacco legislation that bans indoor smoking outright, requiring open-air spaces with at least three open walls.
Tom Ritchie Says: What does the business model look like for a cannabis lounge? If an adult can legally smoke a pre-roll on almost any public sidewalk in Ontario, where is the commercial return on investment for a lounge?
David Brown Says: That is the core economic challenge. Unlike a bar where patrons consume five $10 beers with a 100% markup over three hours, most cannabis consumers smoke a single pre-roll and are satisfied. Spaces like LIT and Joint Craft generate revenue by charging licensed producers and brands for sensory consumer testing, data collection, and budtender educational events rather than surviving solely on beverage and snack margins.
Tom Ritchie Says: Canopy Growth recently announced exporting two 7ACRES cultivars into Australia. Canopy reported a reduced quarterly loss, and people continue to debate how these massive public LPs keep operating.
David Brown Says: In the public cannabis sector, losing tens of millions instead of hundreds of millions is now celebrated as progress! The 7ACRES announcement keeps the legacy brand visible, but the overarching reality is that these major public companies hold massive cash reserves and export lifelines that allow them to endure years of market attrition.
Tom Ritchie Says: Mitchell Osak pointed that out on a recent episode: large public LPs are playing a multi-year war of attrition. They have the treasury to absorb operating losses until smaller competitors exhaust their capital, allowing the survivors to consolidate retail market share.
David Brown Says: Exactly. As long as retail investors continue funding equity raises on the speculative anticipation of US federal legalization, those war chests stay filled. But if that capital dries up or pivots into sectors like artificial intelligence, that attrition timeline will accelerate rapidly.
Tom Ritchie Says: David, thank you for breaking down another packed week of Canadian and global cannabis news on Week in Weed!
David Brown Says: Thanks, Tom. Always a pleasure—let’s connect again soon!
Jump to 01:28
Jump to 04:12
Jump to 03:35
Co-Founder & Editor-in-Chief
David Brown is a Canadian cannabis industry journalist, co-founder of StratCann, and former senior policy adviser for Health Canada.
View Guest Profile ↗
Cannabis Industry News & Media Platform
Stratcann is a Canadian online publication and media platform dedicated to covering news, business developments, regulatory changes, and policy shifts...
Learn More About Partner ↗David Brown explains that Quebec will start allowing cannabis vape pen sales in November. However, the province is maintaining its strict 30% THC potency limit, forcing producers to adapt with high-CBD and custom formulations.
Brown explains that exports allow LPs to clear out old inventory from their vaults, stabilize domestic wholesale prices by reducing oversupply, and generate higher profit margins since international shipments are not subject to the $1-per-gram Canadian excise tax.
Lounges utilize research/sensory testing licenses (such as organoleptic testing licenses) to permit indoor consumption. However, operating these sites as quasi-public lounges may conflict with Health Canada's original intention for medical and scientific testing under the license.
